Education
About Us
Working with TipRanks
Follow Us
Galderma Group AG (CH:GALD)
:GALD
GALD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF62.55 - CHF119.60
Previous CloseN/A
Volume230.69K
Average Volume (3M)1.17M
Market Cap
CHF18.67B
Enterprise ValueCHF26.02B
Total Cash (Recent Filing)-CHF214.15M
Total Debt (Recent Filing)CHF0.00
Price to Earnings (P/E)93.6
Beta0.77
Next Earnings
Jul 24, 2025EPS Estimate
0.99Next Dividend Ex-Date
Apr 25, 2025Dividend YieldN/A
Share Statistics
EPS (TTM)0.85
Shares Outstanding237,897,630
10 Day Avg. Volume627,069
30 Day Avg. Volume1,172,284
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF114.88Price Target Upside19.02% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
---
Galderma Group AG News
---
Bulls Say, Bears Say
Bulls Say
Growth DriversGalderma management suggested that several drivers could accelerate aesthetics growth beyond 2025: innovation and new launches, Sculptra launch in China, and higher growth ex-US.
Market ConfidenceGalderma's mid-term guidance is more ambitious than AbbVie's guidance for high single-digit growth 2025-2029 for their aesthetics franchise, reflecting confidence in market share gain and higher ex-US growth.
Bears Say
Market ConcernsThe selloff despite a decent FY25 guidance reflects concerns around aesthetics and implication for the mid-term.
Pharmaceutical TariffsPharmaceutical tariffs on Therapeutic Derm and Dysport are likely to further affect earnings per share.
Tariffs ImpactReciprocal tariffs on US Fillers and Biostimulators could directly impact earnings per share.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
6.13%
Mutual Funds
― Other Institutional Investors
89.45% Public Companies and
Individual Investors
GALD FAQ
What was Galderma Group AG’s price range in the past 12 months?
Galderma Group AG lowest stock price was CHF62.55 and its highest was CHF119.60 in the past 12 months.
What is Galderma Group AG’s market cap?
Galderma Group AG’s market cap is CHF18.67B.
When is Galderma Group AG’s upcoming earnings report date?
Galderma Group AG’s upcoming earnings report date is Jul 24, 2025 which is in 98 days.
How were Galderma Group AG’s earnings last quarter?
Galderma Group AG released its earnings results on Mar 06, 2025. The company reported CHF0.777 earnings per share for the quarter, the consensus estimate of CHF0.777 by CHF0.
Is Galderma Group AG overvalued?
According to Wall Street analysts Galderma Group AG’s price is currently Undervalued.
Does Galderma Group AG pay dividends?
Galderma Group AG pays a Notavailable dividend of CHF0.084 which represents an annual dividend yield of N/A. See more information on Galderma Group AG dividends here
What is Galderma Group AG’s EPS estimate?
Galderma Group AG’s EPS estimate is 0.99.
How many shares outstanding does Galderma Group AG have?
Galderma Group AG has 237,897,630 shares outstanding.
What happened to Galderma Group AG’s price movement after its last earnings report?
Galderma Group AG reported an EPS of CHF0.777 in its last earnings report, expectations of CHF0.777. Following the earnings report the stock price went down -9.676%.
Which hedge fund is a major shareholder of Galderma Group AG?
Currently, no hedge funds are holding shares in CH:GALD
---
GALD Stock 12 Month Forecast
Average Price Target
CHF114.88
▲(19.02% Upside)
Technical Analysis
Best Analysts Covering GALD
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
-5.85%
reiterated a buy rating 8 days ago
Copying Benjamin Jackson CFA's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -5.85% per trade.
---